# Effect of Dexmedetomidine on Nol-Index Guided Remifentanil Analgesia

> **NCT03912740** · NA · COMPLETED · sponsor: **Erasme University Hospital** · enrollment: 58 (actual)

## Conditions studied

- Nociceptive Pain
- Anesthesia
- Opioid Use
- Perioperative/Postoperative Complications

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** sodium chloride
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT03912740
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-11
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03912740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03912740, "Effect of Dexmedetomidine on Nol-Index Guided Remifentanil Analgesia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03912740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*